Trial Participants: Informed Consent, GCP, Patient Involvement

Regardless of the route used to reach out to potential participants, all advertisements for trial participants should be included in the CTA (as part of the protocol) to be reviewed by the REC.

The format used to recruit participants in the advertisements can be diverse; however, the advertisements should always:

• Include the contact details for the organisation running the clinical trial.
• State the disease studied and purpose of the trial.
• Give the criteria to determine when a patient can take part in the trial.
• Mention the time needed for completing the trial.

On the other hand, advertisements must not:

• Promise a good outcome or a cure for the disease the patient has.
• Be coercive, especially when a trial is trying to recruit vulnerable patients, such as those with learning difficulties.
• State that the medicine being tested is safe or that it works.